Author Response: Insights into Immunomodulatory Therapy for Sepsis

Indranil Ghosh; Sukhwinder S Sangha; Gaurav Pandey; Atul Srivastava

doi:10.5005/jp-journals-10071-24874

SEARCH WITHIN CONTENT

Online First

Author Response: Insights into Immunomodulatory Therapy for Sepsis

Indranil Ghosh, Sukhwinder S Sangha, Gaurav Pandey, Atul Srivastava

Keywords : Sepsis, Hemoperfusion, Immunomodulation

Citation Information : Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response: Insights into Immunomodulatory Therapy for Sepsis. Indian J Crit Care Med 2025; 29 (1):91-91.

DOI: 10.5005/jp-journals-10071-24874

License: CC BY-NC 4.0

Published Online: 30-12-2024

ARTICLE
REFERENCES

Abstract

PDF Share

Jindal A, Angadi VM, Pratyusha K. IJCCM_24_881_R1. Critical insights into novel immunomodulatory therapy for sepsis: Evaluating promise amidst limitations.
Ghosh I, Sangha S, Pandey G, Srivastava A. Efficacy of polymyxin B hemoperfusion for treatment of Sepsis. Indian J Crit Care Med 2024;28(10):930–934. DOI: 10.5005/jp-journals-10071-24805.
Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005;33(6):1266–1271. DOI: 10.1097/01.ccm.0000164543.14619.00.
Chacko B, Ramakrishnan N, Peter JV. Approach to intensive care costing and provision of cost-effective care. Indian J Crit Care Med 2023;27(12):876–887. DOI: 10.5005/jp-journals-10071-24576.
Peter JV, Thomas K, Jeyaseelan L, Yadav B, Sudarsan TI, Christina J, et al. Cost of intensive care in India. Int J Technol Assess Health Care 2016;32(4):241–245. DOI: 10.1017/S0266462316000398.

PDF Share